Ico Therapeutics (ICOTF) 0.0561 $ICOTF iCo Therapeutics

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ico Therapeutics (ICOTF) 0.0561 $ICOTF

iCo Therapeutics Announces First Quarter 2016 Financial Results
CNW Group - Wed May 25, 3:00PM CDT
iCo Therapeutics ("iCo" or "the Company" (TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the quarter ended March 31, 2016. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS".
ICO.VN: 0.070 (unch)

iCo Therapeutics Announces Year End 2015 Financial Results
CNW Group - Thu Apr 14, 3:00PM CDT
iCo Therapeutics ("iCo" or "the Company" (TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the year ended December 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS".
ICO.VN: 0.070 (unch)

iCo Strategic Reorganization
CNW Group - Mon Jan 18, 6:00AM CST
iCo Therapeutics Inc. ("iCo" or "the Company" (TSX-V: ICO) (OTCQX: ICOTF), today announced that effective immediately, in an effort to preserve its asset base and maximize shareholder value, the company is undertaking a strategic re-organization.
ICO.VN: 0.070 (unch)

iCo Therapeutics Announces Changes to Board of Directors
CNW Group - Thu Dec 24, 6:00AM CST
iCo Therapeutics Inc. ("iCo" or "the Company" (TSX-V: ICO) (OTCQX: ICOTF), today announced the appointment of Susan Koppy and John Meekison to iCo's Board of Directors.
ICO.VN: 0.070 (unch), NVS: 82.40 (-0.62)

/C O R R E C T I O N from Source -- iCo Therapeutics Inc./
PR Newswire - Tue Nov 24, 6:21PM CST
In the news release, iCo Therapeutics Announces Third Quarter 2015 Financial Results, issued today by iCo Therapeutics Inc. over CNW, we are advised by the company that in the paragraph Summary Third Quarter 2015 Results, the last sentence should have read "Immune Pharmaceuticals Inc.", rather than "Immune Therapeutics Inc." as originally issued inadvertently. The complete, corrected release follows:
ICO.VN: 0.070 (unch), IMNP: 0.41 (+0.03)

iCo Therapeutics Announces Third Quarter 2015 Financial Results
CNW Group - Tue Nov 24, 4:00PM CST
iCo Therapeutics ("iCo" or "the Company" (TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the quarter ended September 30, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS".
ICO.VN: 0.070 (unch)

iCo Therapeutics Announces Manufacturing Update for Oral Amp B Program
CNW Group - Mon Oct 26, 7:00AM CDT
iCo Therapeutics Inc. ("iCo" or "the Company" (TSX-V: ICO) (OTCQX: ICOTF) today announced that the company has engaged Corealis Pharma Inc. ("Corealis" a contract manufacturing organization, for analytical development, formulation optimization and scale-up of the amphotericin B oral delivery system. The preparation and regulatory filings for this program are expected to be completed in 2016, with Phase 1A study data available in 2017.
ICO.VN: 0.070 (unch)

iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders
PR Newswire - Fri Jun 26, 3:00PM CDT
iCo Therapeutics ("iCo" or "the Company" (TSX-V: ICO) (OTCQX: ICOTF), today announced that all nominees listed in the management information circular dated June 1, 2015 were elected as directors at its 2015 Annual Meeting of Shareholders, held earlier today, June 26 2015. On a vote by ballot, the following 5 nominees proposed by management were elected as Directors of iCo Therapeutics to serve until the Company's next Annual Meeting of Shareholders or until their successors are elected or appointed, with shares represented at the meeting voting in favour of individual nominees as follows:
ICO.VN: 0.070 (unch)

Immune Pharmaceuticals Inc. (Nasdaq: IMNP) to Ring The Nasdaq Stock Market Closing Bell
GlobeNewswire - Fri May 22, 9:00AM CDT
What:
IMNP: 0.41 (+0.03), NDAQ: 70.18 (+1.68)

Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee
PR Newswire - Tue Apr 21, 7:30AM CDT
Immune Pharmaceuticals Inc., or "Immune" (NASDAQ: IMNP) announced that its Board of Directors has elected Rene-Pierre Azria as a Director and the Chair of the Transaction and Pricing Committee, with oversight on strategic and financial transactions. Mr. Azria will also be a member of the Audit Committee, the Compensation Committee and the Corporate Governance and Nomination Committee.
ICO.VN: 0.070 (unch), IMNP: 0.41 (+0.03)

Immune Pharmaceuticals to Develop Novel Topical Nanoparticle Formulation of AmiKet
PR Newswire - Mon Mar 16, 3:15PM CDT
Immune Pharmaceuticals Inc. ("Immune", the "Company" (NASDAQ: IMNP) announced today that it has entered into a binding memorandum of understanding with Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, to license certain of Yissum's patents in order to facilitate the development of a topical nanoparticle formulation of Immune's neuropathic pain drug, AmiKet(TM).
ICO.VN: 0.070 (unch), IMNP: 0.41 (+0.03)

CEO Dr. Daniel Teper of Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) to Be Interviewed Live on Clear Channel - iHeart Business Talk Radio - December 9, 2014
Marketwired - Tue Dec 09, 10:13AM CST
Immune Pharmaceuticals, Inc. (NASDAQ: IMNP), a company that applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer, announced today that CEO Daniel Teper will be interviewed live tomorrow by host Michael Yorba on Clear Channel - iHeart Business Talk Radio's The Traders Network Show. In this exclusive 2-segment interview, Mr. Teper will discuss the company's lead product candidate, Bertilimumab, which is in clinical development for moderate to severe ulcerative colitis and crohn's disease as well as bullous pemphigoid, an orphan auto-immune dermatological condition. We encourage investors, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
IMNP: 0.41 (+0.03)

iCo Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Update
PR Newswire - Fri Nov 28, 4:00PM CST
iCo Therapeutics ("iCo" or "the Company" (TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the nine months ended September 30, 2014. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS".
ICO.VN: 0.070 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 48

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 117

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
Gaotu Techedu's Q3 Results: A Look at AI-Driven Growth

Updated Category News Views 56

Gaotu Techedu to Unveil Q3 Results Mark your calendars, folks—Gaotu Techedu Inc. (NYSE: GOTU) is gearing up to dish out its third quarter financial results on November 25, 2026. As usual, these numbers will slide out before the U.S. markets spring into action. It's one of those moments when investors like us strap in and watch for any movement that might toss our...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 79

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 382

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 59

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 421

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 87

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 87

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading

Top 5 Most Recently Viewed Articles

Choice Hotels Unveils Comprehensive Sustainability Efforts

Updated Category News Views 387

Choice Hotels International Launches 2024 Sustainability Report Choice Hotels International, Inc. (NYSE: CHH), a leading global lodging franchisor, has officially released its 2024 Sustainability Report, showcasing its ongoing commitment to environmental sustainability. The report highlights the company's innovative approaches to reducing its carbon footprint and...

Continue Reading
Revitalizing Communities Through Skilled Trades Initiatives

Updated Category News Views 157

Revitalizing Communities Through Skilled Trades Initiatives In an important moment for many towns across America that are striving for renewal, a new initiative has emerged to shine a light on the necessity of skilled trades. The campaign, titled Careers in Manufacturing, is aimed at highlighting how vital these trades are for both local economies and the workforce on the...

Continue Reading
Color Me Mine Celebrates Growth and Franchise Success

Updated Category News Views 344

Color Me Mine Achieves Remarkable Mid-Year Growth Color Me Mine, a leading paint-your-own pottery franchise, is excited to announce significant growth through its studio expansion and franchisee success. The brand is witnessing a thriving landscape of opportunities, fueled by enthusiastic franchise owners who are making their mark in various communities. Studio Expansion...

Continue Reading
Earnings Insights: Companies Set to Report Soon

Updated Category News Views 202

Upcoming Earnings Reports for Major Companies As the earnings season approaches, investors and analysts eagerly anticipate the financial results from several prominent companies. This article highlights some of the key players expected to announce their quarterly results. Companies Reporting Before the Market Opens UP Fintech Holding (TIGR) UP Fintech Holding is projected...

Continue Reading
Cogent Biosciences Shares Insights at Prestigious Healthcare Event

Updated Category News Views 207

Cogent Biosciences Highlights Participation in Major Healthcare Conference Cogent Biosciences, Inc. (Nasdaq: COGT), a pioneering biotechnology company, is ready to showcase its innovative approach to precision medicine at the highly regarded J.P. Morgan Healthcare Conference. Taking place in San Francisco, this annual event is a crucial platform for industry leaders to...

Continue Reading